| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| INCYTE CORP | EVP, Head of US Oncology | Common Stock | 85.3K | $5.81M | $68.10 | Jul 15, 2025 | Direct |
| INCYTE CORP | EVP, Head of US Oncology | Performance Shares | 21.9K | Jul 15, 2025 | Direct | ||
| INCYTE CORP | EVP, Head of US Oncology | Employee Stock Option (right to buy) | 19.7K | Jul 15, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | Jul 15, 2025 | 3 | $0 | 4 | Jul 17, 2025 | EVP, Head of US Oncology |
| INCY | INCYTE CORP | Jun 30, 2025 | 1 | $0 | 4 | Jul 2, 2025 | EVP, Head of US Oncology |
| INCY | INCYTE CORP | Jan 6, 2025 | 1 | $0 | 4 | Jan 8, 2025 | EVP, Head of US Oncology |
| INCY | INCYTE CORP | Jan 6, 2025 | 0 | $0 | 3 | Jan 8, 2025 | EVP, Head of US Oncology |